Idraparinux and idrabiotaparinux

The pharmacokinetics of idraparinux, a long-acting indirect factor Xa inhibitor: population pharmacokinetic analysis from Phase III clinical trials

(2009) C. VEYRAT-FOLLET et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study

(2008) H. R. Buller et al.   BLOOD

Parenteral Anticoagulants

(2008) Jack Hirsh et al.   CHEST

New Antithrombotic Drugs

(2008) Jeffrey I. Weitz et al.   CHEST

Antithrombotic Therapy in Atrial Fibrillation

(2008) Daniel E. Singer et al.   CHEST

Antithrombotic Therapy for Venous Thromboembolic Disease

(2008) Clive Kearon et al.   CHEST

Pharmacology and Management of the Vitamin K Antagonists

(2008) Jack Ansell et al.   CHEST

Treatment and Prevention of Heparin-Induced Thrombocytopenia

(2008) Theodore E. Warkentin et al.   CHEST

Anticoagulant effects of Idraparinux after termination of therapy for prevention of recurrent venous thromboembolism: observations from the van Gogh trials

(2008) Job Harenberg et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Idraparinux: review of its clinical efficacy and safety for prevention and treatment of thromboembolic disorders

(2008) Paolo Prandoni et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Long elimination half-life of idraparinux may explain major bleeding and recurrent events of patients from the van Gogh trials

(2008) J. HARENBERG et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Reversible biotinylated oligosaccharides: a new approach for a better management of anticoagulant therapy

(2008) P. SAVI et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Cutaneous blood-filled vesicles on idraparinux

(2008) J Benatar et al.   LANCET

Comparison of idraparinux with vitamin K antagonists for prevention of thromboembolism in patients with atrial fibrillation: a randomised, open-label, non-inferiority trial

(2008)   LANCET

Current and Future Prospects for Anticoagulant Therapy: Inhibitors of Factor Xa and Factor IIa

(2008) Job Harenberg et al.   SEMINARS IN THROMBOSIS AND HEMOSTASIS